ExoProTher Medical
Latest round
- Seed
Last raised
- Nov 2022
Total raised
- Undisclosed
Investors
- 1
About ExoProTher Medical
Based in Israel, and founded in 2017 by Alex Tendler (CTO) and Lana Volokh (CEO), ExoProTher Medical operates as a biomedical company that develops and offers novel therapies for the treatment of cancer in humans. As of June 2024, the company is in the preclinical stage of development. The firm’s cancer treatment method focuses on the delivery of healthy p53 protein into tumor cells. This approach targets the p53 tumor suppression mechanism, which is mutated in over 60% of cancers, including glioblastoma, colon, bladder, ovarian, and small-cell lung cancers. ExoProTher aims to restore the body's natural tumor suppression function with minimal side effects by utilizing exosomes and natural nano-particles produced by living cells.
Who invested in ExoProTher Medical
1 investor across 1 round
See all investors in ExoProTher Medical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 1, 2022
Amount
Undisclosed
Investors
Questions about ExoProTher Medical
Who invested in ExoProTher Medical?
ExoProTher Medical has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ExoProTher Medical raised?
ExoProTher Medical has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ExoProTher Medical last raise money?
ExoProTher Medical's most recent round on record is a Seed, in Nov 2022.
What does ExoProTher Medical do?
Based in Israel, and founded in 2017 by Alex Tendler (CTO) and Lana Volokh (CEO), ExoProTher Medical operates as a biomedical company that develops and offers novel therapies for the treatment of cancer in humans.
Where is ExoProTher Medical headquartered?
ExoProTher Medical is headquartered in Nesher, Israel.
Which VCs invest in companies like ExoProTher Medical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at ExoProTher Medical's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like ExoProTher Medical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.